Pacific Biosciences

Pacific Biosciences of California, Inc.
Company type	Public
Traded as	Nasdaq: PACB; Russell 2000 Component;
Industry	Biotechnology
Founded	2004
Headquarters	Menlo Park, California, United States
Key people	Christian Henry (CEO and president); John F. Milligan (chairman of the board);
Revenue	US$200.5 million (2023)
Net income	US$−306.7 million (2023)
Total assets	US$1.75 billion (2023)
Number of employees	796 (Dec 2023)
Website	pacb.com
	Footnotes / references; PacBio Q4 2023 results

37°28′43″N 122°09′03″W / 37.4787°N 122.1507°W / 37.4787; -122.1507 (headquarters)

Preview warning: Page using Template:Infobox company with unknown parameter "cash/equiv"

Pacific Biosciences of California, Inc. (aka PacBio) is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation.^[2]^[3]^{[failed verification]} PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.^[4]^[5]

^ "Pacific Biosciences Form 8-K". U.S. Securities and Exchange Commission. February 15, 2024.
^ bloomberg.com https://www.bloomberg.com/businessweek/globalbiz/content/dec2009/gb2009123_706120.htm. {{cite web}}: Missing or empty |title= (help)^{[permanent dead link]}
^ Brakmann, Susanne (April 5, 2010). "A ribosome in action". Nature. 464 (7291): 987–988. doi:10.1038/464987a. PMID 20393548. S2CID 1742990.
^ Rhoads, Anthony; Au, Kin Fai (October 1, 2015). "PacBio Sequencing and Its Applications". Genomics, Proteomics & Bioinformatics. 13 (5): 278–289. doi:10.1016/j.gpb.2015.08.002. ISSN 1672-0229. PMC 4678779. PMID 26542840.
^ Eisenstein, Michael (January 1, 2023). "Illumina faces short-read rivals". Nature Biotechnology. 41 (1): 3–5. doi:10.1038/s41587-022-01632-4. ISSN 1546-1696. PMID 36653497. S2CID 255971472. Retrieved Mar 8, 2023.

[10K-1] "Pacific Biosciences Form 8-K". U.S. Securities and Exchange Commission. February 15, 2024.

[businessweek.com-2] bloomberg.com https://www.bloomberg.com/businessweek/globalbiz/content/dec2009/gb2009123_706120.htm. {{cite web}}: Missing or empty |title= (help)^{[permanent dead link]}

[brakmann2010-3] Brakmann, Susanne (April 5, 2010). "A ribosome in action". Nature. 464 (7291): 987–988. doi:10.1038/464987a. PMID 20393548. S2CID 1742990.

[Rhoads-4] Rhoads, Anthony; Au, Kin Fai (October 1, 2015). "PacBio Sequencing and Its Applications". Genomics, Proteomics & Bioinformatics. 13 (5): 278–289. doi:10.1016/j.gpb.2015.08.002. ISSN 1672-0229. PMC 4678779. PMID 26542840.

[5] Eisenstein, Michael (January 1, 2023). "Illumina faces short-read rivals". Nature Biotechnology. 41 (1): 3–5. doi:10.1038/s41587-022-01632-4. ISSN 1546-1696. PMID 36653497. S2CID 255971472. Retrieved Mar 8, 2023.

[1]

[2]

[3]

[4]

[5]